Report Library
All Reports
2018 JP Morgan Conference Review
January 18, 2018
The 36th annual JP Morgan Healthcare Conference was held in San Francisco, CA from January 8-11, 2018. A full list of events and catalysts that were announced or updated during the conference is included in this report.
Highlights from the company presentations and additional commentary from Pink Sheet and Scrip are included as follows:
Large/Mega Cap Companies
For the full report, please download the PDF version at the top of this page.
For our disclosures, please read the Biomedtracker Research Standards.
Highlights from the company presentations and additional commentary from Pink Sheet and Scrip are included as follows:
Large/Mega Cap Companies
- Celgene (CELG)
- Incyte (INCY)
- Gilead (GILD)
- Biogen (BIIB)
- Amgen (AMGN)
- Vertex (VRTX)
- Alnylam (ALNY)
- Regeneron (REGN)
- Alexion (ALXN)
- Pfizer (PFE)
- Roche (RHHBY)
- Novartis (NVS)
- Merck (MRK)
- AbbVie (ABBV)
- Sanofi (SNY)
- Bristol-Myers Squibb (BMY)
- Allergan (AGN)
- Astellas (ALPMY)
- Daiichi Sankyo (DSNKY)
- Merck KGaA (MKGAY)
- Ionis (IONS)
- Spark Therapeutics (ONCE)
- Sarepta Therapeutics (SRPT)
- The Medicines Company (MDCO)
- Agios Pharmaceuticals (AGIO)
- Amicus Therapeutics (FOLD)
- Nektar Therapeutics (NKTR)
- Alkermes (ALKS)
- SAGE Therapeutics (SAGE)
- Apellis Pharmaceuticals (APLS)
- Bluebird Bio (BLUE)
- Acadia Pharmaceuticals (ACAD)
- Halozyme Therapeutics (HALO)
- Clovis Oncology (CLVS)
- Juno Therapeutics (JUNO)
- Horizon Pharma (HZNP)
- Ultragenyx (RARE)
- MorphoSys (MPSYF)
- Prothena (PRTA)
- Valeant (VRX)
- Hanmi Pharmaceuticals
- Immunomedics (IMMU)
- Array BioPharma (ARRY)
- Alder (ALDR)
- Ascendis Pharma (ASND)
- Acceleron Pharma (XLRN)
- Radius Health (RDUS)
- Ablynx (ABLX)
- Dova Pharmaceutical (DOVA)
- Cellectis (CLLS)
- Amag Pharmaceuticals (AMAG)
- Lexicon Pharmaceuticals (LXRX)
- Myokardia (MYOK)
- Audentes Therapeutics (BOLD)
- Rigel Pharmaceuticals (RIGL)
- Global Blood Therapeutics (GBT)
- Clementia Pharmaceuticals (CMTA)
- Amarin (AMRN)
- Esperion Therapeutics (ESPR)
- Myovant Sciences (MYOV)
- Sangamo Therapeutics (SGMO)
- Editas Medicine (EDIT)
- Karyopharm Therapeutics (KPTI)
- Keryx Biopharmaceuticals (KERX)
- Novocure (NVCR)
- TG Therapeutics (TGTX)
- Vifor Pharma (VIFN; Galenica)
- NewLink Genetics (NLNK)
- Seres Therapeutics (MCRB)
- MacroGenics (MGNX)
- AVEO Oncology (AVEO)
- Retrophin (RTRX)
- CymaBay (CBAY)
- Dynavax (DVAX)
- Axovant Sciences (AXON)
- Otonomy (OTIC)
- Syros (SYRS)
- aTyr (LIFE)
For the full report, please download the PDF version at the top of this page.
For our disclosures, please read the Biomedtracker Research Standards.
| Disease Group Covered: |
Allergy
Autoimmune/immunology Cardiovascular Dermatology Endocrine ENT/Dental Gastroenterology (Non Inflammatory Bowel Disease) Hematology Infectious Disease Metabolic Neurology Not Specified Obstetrics/Gynecology Oncology Ophthalmology Orthopedics Psychiatry Renal Respiratory Rheumatology (Non Autoimmune) Urology |
Additional Resources: